These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 10348465)

  • 21. [Striatonigral degeneration and sporadic olivopontocerebellar atrophy: a consideration of the clinical entity of multiple system atrophy].
    Miwa H; Kondo T; Mizuno Y
    No To Shinkei; 1999 Apr; 51(4):305-12. PubMed ID: 10363264
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Differences in [99mTc]TRODAT-1 SPECT binding to dopamine transporters in patients with multiple system atrophy and Parkinson's disease.
    Swanson RL; Newberg AB; Acton PD; Siderowf A; Wintering N; Alavi A; Mozley PD; Plossl K; Udeshi M; Hurtig H
    Eur J Nucl Med Mol Imaging; 2005 Mar; 32(3):302-7. PubMed ID: 15791439
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Deficit of brain and skeletal muscle bioenergetics in progressive supranuclear palsy shown in vivo by phosphorus magnetic resonance spectroscopy.
    Martinelli P; Scaglione C; Lodi R; Iotti S; Barbiroli B
    Mov Disord; 2000 Sep; 15(5):889-93. PubMed ID: 11009196
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Somatosensory temporal discrimination threshold may help to differentiate patients with multiple system atrophy from patients with Parkinson's disease.
    Rocchi L; Conte A; Nardella A; Li Voti P; Di Biasio F; Leodori G; Fabbrini G; Berardelli A
    Eur J Neurol; 2013 Apr; 20(4):714-9. PubMed ID: 23278905
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Increased brain histamine levels in Parkinson's disease but not in multiple system atrophy.
    Rinne JO; Anichtchik OV; Eriksson KS; Kaslin J; Tuomisto L; Kalimo H; Röyttä M; Panula P
    J Neurochem; 2002 Jun; 81(5):954-60. PubMed ID: 12065607
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Comparison of diffusion-weighted imaging and [123I]IBZM-SPECT for the differentiation of patients with the Parkinson variant of multiple system atrophy from those with Parkinson's disease.
    Seppi K; Schocke MF; Donnemiller E; Esterhammer R; Kremser C; Scherfler C; Diem A; Jaschke W; Wenning GK; Poewe W
    Mov Disord; 2004 Dec; 19(12):1438-45. PubMed ID: 15390073
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Twenty-four-hour ambulatory blood pressure and heart rate profiles in diagnosing orthostatic hypotension in Parkinson's disease and multiple system atrophy.
    Vichayanrat E; Low DA; Iodice V; Stuebner E; Hagen EM; Mathias CJ
    Eur J Neurol; 2017 Jan; 24(1):90-97. PubMed ID: 27718292
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Evaluation of autonomic functions of patients with multiple system atrophy and Parkinson's disease by head-up tilt test.
    Watano C; Shiota Y; Onoda K; Sheikh AM; Mishima S; Nitta E; Yano S; Yamaguchi S; Nagai A
    J Neural Transm (Vienna); 2018 Feb; 125(2):153-162. PubMed ID: 29185078
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Altered α-synuclein, parkin, and synphilin isoform levels in multiple system atrophy brains.
    Brudek T; Winge K; Rasmussen NB; Bahl JM; Tanassi J; Agander TK; Hyde TM; Pakkenberg B
    J Neurochem; 2016 Jan; 136(1):172-85. PubMed ID: 26465922
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Comparative cognitive and neuropsychiatric profiles between Parkinson's disease, multiple system atrophy and progressive supranuclear palsy.
    Santangelo G; Cuoco S; Pellecchia MT; Erro R; Barone P; Picillo M
    J Neurol; 2018 Nov; 265(11):2602-2613. PubMed ID: 30178175
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Pelvic organ dysfunction is more prevalent and severe in MSA-P compared to Parkinson's disease.
    Yamamoto T; Sakakibara R; Uchiyama T; Yamaguchi C; Nomura F; Ito T; Yanagisawa M; Yano M; Awa Y; Yamanishi T; Hattori T; Kuwabara S
    Neurourol Urodyn; 2011 Jan; 30(1):102-7. PubMed ID: 20658542
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Low brain intracellular free magnesium in mitochondrial cytopathies.
    Barbiroli B; Iotti S; Cortelli P; Martinelli P; Lodi R; Carelli V; Montagna P
    J Cereb Blood Flow Metab; 1999 May; 19(5):528-32. PubMed ID: 10326720
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Imaging of dopamine transporters and D2 receptors in patients with Parkinson's disease and multiple system atrophy.
    Knudsen GM; Karlsborg M; Thomsen G; Krabbe K; Regeur L; Nygaard T; Videbaek C; Werdelin L
    Eur J Nucl Med Mol Imaging; 2004 Dec; 31(12):1631-8. PubMed ID: 15583914
    [TBL] [Abstract][Full Text] [Related]  

  • 34. In vivo assessment of Mg2+ in human brain and skeletal muscle by 31P-MRS.
    Iotti S; Malucelli E
    Magnes Res; 2008 Sep; 21(3):157-62. PubMed ID: 19009818
    [TBL] [Abstract][Full Text] [Related]  

  • 35. MIBG scintigraphy for differentiating Parkinson's disease with autonomic dysfunction from Parkinsonism-predominant multiple system atrophy.
    Chung EJ; Lee WY; Yoon WT; Kim BJ; Lee GH
    Mov Disord; 2009 Aug; 24(11):1650-5. PubMed ID: 19514077
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Brain energy metabolism in early MSA-P: A phosphorus and proton magnetic resonance spectroscopy study.
    Stamelou M; Pilatus U; Reuss A; Respondek G; Knake S; Oertel WH; Höglinger GU
    Parkinsonism Relat Disord; 2015 May; 21(5):533-5. PubMed ID: 25801909
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Characteristics of idiopathic REM sleep behavior disorder and that associated with MSA and PD.
    Iranzo A; Santamaría J; Rye DB; Valldeoriola F; Martí MJ; Muñoz E; Vilaseca I; Tolosa E
    Neurology; 2005 Jul; 65(2):247-52. PubMed ID: 16043794
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [[123I]beta-CIT SPECT imaging of dopamine and serotonin transporters in Parkinson's disease and multiple system atrophy.
    Berding G; Brücke T; Odin P; Brooks DJ; Kolbe H; Gielow P; Harke H; Knoop BO; Dengler R; Knapp WH
    Nuklearmedizin; 2003 Feb; 42(1):31-8. PubMed ID: 12601452
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The value of brain perfusion SPECT for differentiation between mildly symptomatic idiopathic Parkinson's disease and the Parkinson variant of multiple system atrophy.
    Song IU; Yoo I; Chung YA; Jeong J
    Nucl Med Commun; 2015 Oct; 36(10):1049-54. PubMed ID: 26087241
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Lysosomal response in relation to α-synuclein pathology differs between Parkinson's disease and multiple system atrophy.
    Puska G; Lutz MI; Molnar K; Regelsberger G; Ricken G; Pirker W; Laszlo L; Kovacs GG
    Neurobiol Dis; 2018 Jun; 114():140-152. PubMed ID: 29505813
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.